0001493152-20-011761.txt : 20200624 0001493152-20-011761.hdr.sgml : 20200624 20200624210020 ACCESSION NUMBER: 0001493152-20-011761 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200623 FILED AS OF DATE: 20200624 DATE AS OF CHANGE: 20200624 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ende Eric J CENTRAL INDEX KEY: 0001494386 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38022 FILM NUMBER: 20986878 MAIL ADDRESS: STREET 1: C/O MATINAS BIOPHARMA HOLDINGS, INC. STREET 2: 1545 ROUTE 206 SOUTH, SUITE 302 CITY: BEDMINSTER STATE: NJ ZIP: 07921 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Matinas BioPharma Holdings, Inc. CENTRAL INDEX KEY: 0001582554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463011414 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1545 ROUTE 206 SOUTH STREET 2: SUITE 302 CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: 908-443-1860 MAIL ADDRESS: STREET 1: 1545 ROUTE 206 SOUTH STREET 2: SUITE 302 CITY: BEDMINSTER STATE: NJ ZIP: 07921 4 1 ownership.xml X0306 4 2020-06-23 0 0001582554 Matinas BioPharma Holdings, Inc. MTNB 0001494386 Ende Eric J C/O MATINAS BIOPHARMA HOLDINGS, INC. 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER, NJ 07921 1 0 0 0 Common Stock, par value $0.0001 per share 2020-06-23 5 J 0 E 3600 0 A 115292 D Stock dividend, payable to all holders of record of Series B Preferred Stock of 300 shares of Common Stock for each share of Series B Preferred Stock. /s/_Keith A. Kucinski, attorney-in fact for Eric J. Ende 2020-06-24